| Company/Division name | PENDING-Alcon Laboratories Inc. |
| Parent company | PENDING-Alcon Laboratories Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 240 |
| Year reshoring announced: | 2025 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 186 |
| Country(ies) from which reshored: | Switzerland |
| City reshored to: | Fort Worth |
| State(s) reshored to: | TX |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | medical devices; lenses and oculuar products |
| What domestic positive factors made reshoring more attractive? | Government Incentives |
| Government Incentive dollar amount: | 6,000,000 |
